| __timestamp | Alpine Immune Sciences, Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 246000000 |
| Thursday, January 1, 2015 | 16054000 | 582800000 |
| Friday, January 1, 2016 | 23316000 | 455000000 |
| Sunday, January 1, 2017 | 10626000 | 366000000 |
| Monday, January 1, 2018 | 28970000 | 414000000 |
| Tuesday, January 1, 2019 | 35847000 | 471000000 |
| Wednesday, January 1, 2020 | 27185000 | 452000000 |
| Friday, January 1, 2021 | 58742000 | 465000000 |
| Saturday, January 1, 2022 | 70243000 | 529000000 |
| Sunday, January 1, 2023 | 80904000 | 604000000 |
Unleashing the power of data
In the competitive landscape of biotechnology and pharmaceuticals, innovation is the lifeblood of progress. Alpine Immune Sciences, Inc. and Bausch Health Companies Inc. have been at the forefront of this race, each with a distinct approach to research and development (R&D) investments.
Over the past decade, Bausch Health has consistently outpaced Alpine Immune Sciences in R&D spending, with an average annual investment nearly 12 times greater. In 2023, Bausch Health allocated approximately $604 million to R&D, marking a 146% increase from 2014. Meanwhile, Alpine Immune Sciences has shown a remarkable growth trajectory, increasing its R&D expenses by over 560% since 2014, reaching around $81 million in 2023.
This data underscores the diverse strategies these companies employ to drive innovation, with Bausch Health leveraging its scale and Alpine Immune Sciences focusing on rapid growth.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Zoetis Inc. or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Regeneron Pharmaceuticals, Inc. vs Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for GSK plc and Alpine Immune Sciences, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Research and Development Investment: Axsome Therapeutics, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CymaBay Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated